Fundraising FoxAlphabet — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.
BiotechCambridge, US
Ankit Mahadevia(Executive Officer, Director)inStephen Garbacz(Executive Officer)inEsther Rajavelu(Director, President, Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer)in
BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)
Co-investorsGV (Google Ventures)HEALTHCARE ROYALTY PARTNERSMRL Ventures FundOUP (Osage University Partners)RA CapitalAtlas Venture+1 more
Safe Superintelligence Inc. develops AI systems focused on building safe superintelligence through aligned research and engineering.
AI & Machine LearningDeep TechPalo Alto, US
Daniel Levy(Founder)inIlya Sutskever(Founder)inDaniel Gross(Founder)in
Co-investorsAndreessen HorowitzDataPower VenturesSequoia CapitalDST GlobalGreenoaksLightspeed Venture Partners+1 more
Waymo develops autonomous ride-hailing and delivery services using self-driving vehicle technology.
AI & Machine LearningMobility & TransportationRoboticsSan Francisco, US
Tekedra Mawakana(Co-Chief Executive Officers)inDmitri Dolgov(Co-Chief Executive Officers)inAnthony Levandowski(Founder)Chris Urmson(Founder)Sebastian Thrun(Founder)in
Co-investorsAndreessen HorowitzBessemer Venture PartnersCapitalGDataPower VenturesElad GilGV (Google Ventures)+12 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.